论文部分内容阅读
目的:分析缩宫素结合米索前列醇预防剖宫产术后出血的临床应用效果。方法:选取2013年5月至2015年5月到该院行剖宫产患者60例,随机进行分组,其中对照组为30例,研究组为30例,给予对照组缩宫素治疗预防产后出血,给予研究组缩宫素结合米索前列醇治疗预防产后出血,分析对比两组患者术后出血发生率、不良反应发生率以及术后两小时平均出血量。结果:研究组在产后出血发生率、不良反应发生率以及术后两小时平均出血量均明显低于对照组,组间数据对比差异明显(P<0.05)具有统计学意义。结论:对行剖宫产患者来说,联合使用缩宫素结合米索前列醇可预防产后出血,不良反应率低,值得在临床中推广。
Objective: To analyze the clinical effect of oxytocin combined with misoprostol in preventing bleeding after cesarean section. Methods: From May 2013 to May 2015, 60 cases of cesarean section were randomly divided into control group, 30 cases in control group and 30 cases in study group. Oxytocin was given to the control group to prevent postpartum hemorrhage , To give the study group oxytocin combined with misoprostol treatment to prevent postpartum hemorrhage, analysis of the incidence of postoperative bleeding in two groups, the incidence of adverse reactions and average blood loss after two hours. Results: The incidence of postpartum hemorrhage, the incidence of adverse reactions, and the average amount of bleeding after two hours in the study group were significantly lower than those in the control group. There was significant difference between the two groups (P <0.05). Conclusion: For patients with cesarean section, the combination of oxytocin and misoprostol can prevent postpartum hemorrhage with low adverse reaction rate, which is worth to be popularized clinically.